Objectives: To examine patients’ perspectives regarding composite endpoints and the utility patients put on possible adverse outcomes of revascularization procedures. Design: In the PRECORE study, a stated preference elicitation method Best-Worst Scaling (BWS) was used to determine patient preference for 8 component endpoints (CEs): need for redo percutaneous coronary intervention (PCI) within 1 year, minor stroke with symptoms <24 hours, minor myocardial infarction (MI) with symptoms <3 months, recurrent angina pectoris, need for redo coronary artery bypass grafting (CABG) within 1 year, major MI causing permanent disability, major stroke causing permanent disability and death within 24 hours. Setting: A tertiary PCI/CABG centre. Participa...
This article considers the combination of two binary or two time-to-event endpoints to form the prim...
Well-conducted randomized controlled trials are instrumental in providing vital data on safety and e...
Although composite endpoints (CE) are common in clinical trials, the impact of the relationship betw...
Background Because composite end points augment event rates, they are often thought to increase stat...
BACKGROUND: Because composite end points augment event rates, they are often thought to increase sta...
Background: To reduce the duration and overall costs of cardiovascular trials, use of the combined e...
A composite end point is often used as the primary end point to assess the efficacy of a new treatme...
Background: To reduce the duration and overall costs of cardiovascular trials, use of the combined e...
Background – A composite endpoint is often used as the primary endpoint to assess the efficacy of a ...
Background: Composite measures combine data to provide a comprehensive view of patient outcomes. Des...
2 Background—Many clinical trials use composite endpoints to reduce sample size, but the relative im...
BACKGROUND: Composite end points are common in clinical trials. OBJECTIVE: To describe how composite...
The decision on the primary endpoint in a randomized clinical trial is of paramount importance and t...
Clinicians, institutions, healthcare networks, and policymakers use outcomes reported in clinical tr...
Carlos Alberto da Silva Magliano,1 Andrea Liborio Monteiro,2 Bernardo Rangel Tura,1 Claudia Silvia R...
This article considers the combination of two binary or two time-to-event endpoints to form the prim...
Well-conducted randomized controlled trials are instrumental in providing vital data on safety and e...
Although composite endpoints (CE) are common in clinical trials, the impact of the relationship betw...
Background Because composite end points augment event rates, they are often thought to increase stat...
BACKGROUND: Because composite end points augment event rates, they are often thought to increase sta...
Background: To reduce the duration and overall costs of cardiovascular trials, use of the combined e...
A composite end point is often used as the primary end point to assess the efficacy of a new treatme...
Background: To reduce the duration and overall costs of cardiovascular trials, use of the combined e...
Background – A composite endpoint is often used as the primary endpoint to assess the efficacy of a ...
Background: Composite measures combine data to provide a comprehensive view of patient outcomes. Des...
2 Background—Many clinical trials use composite endpoints to reduce sample size, but the relative im...
BACKGROUND: Composite end points are common in clinical trials. OBJECTIVE: To describe how composite...
The decision on the primary endpoint in a randomized clinical trial is of paramount importance and t...
Clinicians, institutions, healthcare networks, and policymakers use outcomes reported in clinical tr...
Carlos Alberto da Silva Magliano,1 Andrea Liborio Monteiro,2 Bernardo Rangel Tura,1 Claudia Silvia R...
This article considers the combination of two binary or two time-to-event endpoints to form the prim...
Well-conducted randomized controlled trials are instrumental in providing vital data on safety and e...
Although composite endpoints (CE) are common in clinical trials, the impact of the relationship betw...